ASP Isotopes (ASPI) Cash & Equivalents (2021 - 2026)

ASP Isotopes' Cash & Equivalents history runs 6 years deep, the most recent figure standing at $207.3 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 270.49% year-over-year to $207.3 million; the TTM figure through Mar 2026 stood at $207.3 million (up 270.49% YoY), while the FY2025 annual figure was $267.4 million, up 332.06% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $207.3 million, down from $267.4 million in the prior quarter.
• The five-year high for Cash & Equivalents was $267.4 million in Q4 2025, with the low at $431565.0 in Q3 2022.
• The 5-year median for Cash & Equivalents is $23.9 million (2024), against an average of $53.3 million.
• The sharpest annual moves came in 2022 and 2024: Cash & Equivalents fell 19.11% in 2022, then soared 2155.18% in 2024.
• ASP Isotopes' Cash & Equivalents stood at $2.4 million in 2022, then surged by 231.0% to $7.9 million in 2023, then surged by 682.63% to $61.9 million in 2024, then surged by 332.06% to $267.4 million in 2025, then retreated by 22.46% to $207.3 million in 2026.
• Business Quant data shows ASPI's Cash & Equivalents at $207.3 million in Q1 2026, $267.4 million in Q4 2025, and $113.9 million in Q3 2025.